Antihemophilic Factor (recombinant) Pegylated-aucl
Generic Name: antihemophilic factor (recombinant) pegylated-aucl
Brand Names:
Jivi
Dosage form: KIT. Category: BLA.
Overview
Dosage form: KIT. Category: BLA.
Dosage
Available as kit.
Related Medications
Connective Tissue Liquescence
connective tissue liquescence
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Ragweed Tall Giant
ragweed tall giant
Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: AMBROSIA TRIFIDA POLLEN (.1 g/mL). Category: BLA.
Margetuximab-cmkb
margetuximab-cmkb
HER2/neu Receptor Antagonist [EPC]
11 DESCRIPTION Margetuximab-cmkb, a HER2/neu receptor antagonist, is a chimeric Fc-engineered IgG1 kappa monoclonal antibody. Margetuximab-cmkb is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. Margetuximab-cmkb has an approximate molecular weight of 149 kDa. MARGENZA (margetuximab-cmkb) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to pale yellow or pale brown solution that requires dilution for intravenous use.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.